个人中心 - 老虎社区

SGHuatZai

IP属地：未知

帖子 · 10帖子 · 10
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- SGHuatZaiSGHuatZai
  ·2021-07-21
  Great
  Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance<blockquote>Moderna股票在进入标普500之前“已经拥有了自己的生命”</blockquote>
  Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc.
  Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance<blockquote>Moderna股票在进入标普500之前“已经拥有了自己的生命”</blockquote>
  746 1
  2
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-07-21
  Solid
  非常抱歉，此主贴已删除
  955 评论
  5
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-06-30
  Wow
  非常抱歉，此主贴已删除
  1,893 评论
  3
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-06-24
  Nice
  非常抱歉，此主贴已删除
  1,650 评论
  4
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-06-20
  Like and comment pls
  非常抱歉，此主贴已删除
  1,042 2
  3
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-06-19
  Shucks
  非常抱歉，此主贴已删除
  1,882 评论
  3
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-05-27
  Nicely done
  非常抱歉，此主贴已删除
  2,240 评论
  2
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-05-11
  Like and comment pls
  非常抱歉，此主贴已删除
  1,103 2
  3
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-04-29
  Flyyyyy
  非常抱歉，此主贴已删除
  1,108 评论
  点赞
  分享
  举报
- SGHuatZaiSGHuatZai
  ·2021-04-28
  Amazing 👍🏻
  AMD stock rises after earnings show data-center sales more than doubling<blockquote>财报显示数据中心销售额增长一倍多后，AMD股价上涨</blockquote>
  AMD increases full-year revenue guidance after record quarterly sales, stock jumps more than 3% in e
  AMD stock rises after earnings show data-center sales more than doubling<blockquote>财报显示数据中心销售额增长一倍多后，AMD股价上涨</blockquote>
  875 评论
  3
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3567633296951464","uuid":"3567633296951464","gmtCreate":1604539273995,"gmtModify":1606565405120,"name":"SGHuatZai","pinyin":"sghuatzai","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":29,"tweetSize":10,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.01","exceedPercentage":"80.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":178480670,"gmtCreate":1626831765790,"gmtModify":1631886459237,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/178480670","repostId":"1120529749","repostType":4,"repost":{"id":"1120529749","kind":"news","pubTimestamp":1626831113,"share":"https://www.laohu8.com/m/news/1120529749?lang=zh_CN&edition=full","pubTime":"2021-07-21 09:31","market":"us","language":"en","title":"Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance<blockquote>Moderna股票在进入标普500之前“已经拥有了自己的生命”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1120529749","media":"finance.yahoo","summary":"Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc.","content":"<p>Moderna (MRNA) is set to join the S&amp;P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock hassoaredamid the pandemic after its vaccine became instrumental in the fight against coronavirus.</p><p><blockquote>Moderna(MRNA)将于周三加入标普500指数，取代Alexion Pharmaceuticals Inc.(ALXN)。在其疫苗在对抗冠状病毒方面发挥作用后，该股在大流行期间飙升。</blockquote></p><p> Moderna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It's priced in a huge amount of assumptions over the next ten years that haven't played out yet. People believe it’s the Tesla of biotech.”</p><p><blockquote>杰富瑞(Jefferies)董事总经理兼高级研究分析师Michael Yee告诉雅虎财经（上面的视频），Moderna股票已经“拥有了自己的生命”。“它的定价包含了未来十年尚未实现的大量假设。人们相信这是生物技术的特斯拉。”</blockquote></p><p> That the biotech firm would be so well-recognized and valued at over $113 billion was no sure bet. For those who invested early in the company, that wager paid off.</p><p><blockquote>这家生物技术公司会得到如此广泛的认可并估值超过1130亿美元，这并不是一个确定的赌注。对于那些早期投资该公司的人来说，这一赌注得到了回报。</blockquote></p><p> \"Think about how fast they came up with nothing a year ago, and all of a sudden, they're doing $21 billion and have injected hundreds and hundreds and hundreds of millions of people with their drug safely,\" Yee said. \"That's a pretty big accomplishment.\"</p><p><blockquote>“想想看，一年前他们什么也没拿出，但突然之间，他们就赚了210亿美元，并为数以亿计的人安全地注射了药物，”Yee说。“这是一个相当大的成就。”</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bb60075c3a90de67d77af15634fd41fa\" tg-width=\"858\" tg-height=\"588\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Moderna's rise to recognition</b></p><p><blockquote><b>Moderna获得认可</b></blockquote></p><p> The Cambridge, Massachusetts-based biotech company was founded in 2010 and spent its first two years instealth modedeveloping drugs using messenger RNA (mRNA).</p><p><blockquote>这家总部位于马萨诸塞州剑桥的生物技术公司成立于2010年，头两年一直在秘密开发使用信使RNA(mRNA)的药物。</blockquote></p><p> The promise of mRNA — what Moderna calls \"the software of life\" — in pharmaceuticals has been huge. Modified mRNA teaches cells how to produce the proteins needed to fight and prevent infection. By altering the four letters in an mRNA sequence, this new class of drugs can, in theory, target a wide range of illnesses. The mRNA platform also promises to accelerate the time it takes to select, develop, and manufacture vaccines.</p><p><blockquote>mRNA——现代评级的“生命软件”——在制药领域的前景是巨大的。修饰的mRNA教会细胞如何产生对抗和预防感染所需的蛋白质。通过改变mRNA序列中的四个字母，这种新型药物理论上可以针对多种疾病。mRNA平台还有望加快选择、开发和制造疫苗所需的时间。</blockquote></p><p> On these high expectations, Moderna achieved a billion-dollar valuation within two years. Initially, the company focused its efforts on treatments for cancer, cardiovascular issues, and some rare diseases. However, developers were embattled with the problem of delivering mRNA to cells — too-strong doses set the body's immune system against the drug while too-weak doses proved ineffectual in fighting disease.</p><p><blockquote>在这些高期望上，Moderna在两年内实现了10亿美元的估值。最初，该公司专注于癌症、心血管问题和一些罕见疾病的治疗。然而，开发人员面临着向细胞输送mRNA的问题——太强的剂量会使人体的免疫系统对药物产生抵抗力，而太弱的剂量则被证明对对抗疾病无效。</blockquote></p><p> Over time, the company shifted to pursuing vaccines, which CEO Stéphane Bancel believed would demonstrate the viability of the technology. Moderna had nine vaccines that made it to clinical trials, although none achieved liftoff.</p><p><blockquote>随着时间的推移，该公司转向开发疫苗，首席执行官Stéphane Bancel认为这将证明该技术的可行性。Moderna有九种疫苗进入临床试验，但没有一种疫苗成功上市。</blockquote></p><p> That changed when a deadly global pandemic hit, kicking off a vaccine race in the U.S. between Moderna and pharmaceutical titans like Pfizer (who also developed an mRNA vaccine in partnership with BioNTech) and Johnson &amp; Johnson.</p><p><blockquote>当致命的全球大流行来袭时，情况发生了变化，Moderna与辉瑞（辉瑞也与BioNTech合作开发了mRNA疫苗）和强生等制药巨头在美国开始了疫苗竞赛。</blockquote></p><p> The company's decade of research iterating on the basic science behind mRNA proved consequential in its success in developing a coronavirus vaccine in record time. On January 11, 2020, Chinese scientists revealed the genetic sequence for SARS-CoV-2. By February 24, 2020, Moderna shipped thefirst dosesof its mRNA coronavirus vaccine to the NIAID to begin phase I trials. And in December of 2020, phase III trials demonstrated 94.1% efficacy against symptomatic COVID-19. The FDA subsequently approved Moderna's vaccine for emergency use in the United States, Canada, and the European Union.</p><p><blockquote>事实证明，该公司对mRNA背后的基础科学进行了十年的迭代研究，对其在创纪录的时间内成功开发出冠状病毒疫苗至关重要。2020年1月11日，中国科学家揭示了新型冠状病毒病毒的基因序列。到2020年2月24日，Moderna将第一剂mRNA冠状病毒疫苗运送到NIAID，开始I期试验。2020年12月，III期试验显示对有症状的COVID-19有94.1%的疗效。FDA随后批准Moderna的疫苗在美国、加拿大和欧盟紧急使用。</blockquote></p><p> Moderna's COVID-19 vaccine marks its first — and only — commercially available product. On the back of strong demand for the vaccine, the company recorded its first-everprofitable quarterin Q1.</p><p><blockquote>Moderna的COVID-19疫苗标志着其第一个也是唯一一个商业化的产品。由于对疫苗的强劲需求，该公司在第一季度首次实现盈利。</blockquote></p><p> The company currently has 23 othervaccines and therapeuticsin its pipeline, including vaccines for the flu, HIV, and Cytomegalovirus (CMV), which causes birth defects in newborns, all using the same mRNA technology that has seen validation from the rollout of the COVID-19 vaccine.</p><p><blockquote>该公司目前还有23种其他疫苗和治疗药物，包括流感、艾滋病毒和导致新生儿出生缺陷的巨细胞病毒(CMV)疫苗，所有这些疫苗都使用相同的mRNA技术，该技术已在COVID-19的推出中得到验证-19疫苗。</blockquote></p><p> \"I think depending on your long-term outlook of what this company could do and all of the pipeline drugs that theoretically could come about over the next 10 years, based on those prospects, it could and should be one of the largest biotech companies in the world,\" Yee said.</p><p><blockquote>“我认为，根据你对这家公司可以做什么的长期前景以及理论上未来10年可能出现的所有管道药物，基于这些前景，它可以而且应该成为世界上最大的生物技术公司之一，”Yee说。</blockquote></p><p> <b>A bull market in biotech</b></p><p><blockquote><b>生物技术牛市</b></blockquote></p><p> The biotech industry has seen a phenomenal run-up in the last several years, and any pullbacks in the last six months should be viewed in that context, Yee also noted.</p><p><blockquote>Yee还指出，生物技术行业在过去几年中经历了惊人的增长，过去六个月的任何回调都应该在这种背景下看待。</blockquote></p><p> \"It has been one of the biggest bull markets in biotech in the last three years,\" he said, citing high valuations as well as record numbers of financings, investment, and IPOs.</p><p><blockquote>“这是过去三年生物技术领域最大的牛市之一，”他表示，并引用了高估值以及创纪录的融资、投资和IPO数量。</blockquote></p><p> Going forward, Yee expects more M&amp;A activity. \"Some of the large companies which are more mature, I think, are having some struggles. And the way they've solved that is often by buying smaller companies,\" he said. \"In the big picture, things have still been very good for biotech.\"</p><p><blockquote>展望未来，Yee预计并购活动将会增加。“我认为，一些更成熟的大公司正在遇到一些困难。他们解决这个问题的方法通常是收购较小的公司，”他说。“从大局来看，生物技术的情况仍然非常好。”</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock 'has taken on a life of its own' ahead of S&P 500 entrance<blockquote>Moderna股票在进入标普500之前“已经拥有了自己的生命”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock 'has taken on a life of its own' ahead of S&P 500 entrance<blockquote>Moderna股票在进入标普500之前“已经拥有了自己的生命”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">finance.yahoo</strong><span class=\"h-time small\">2021-07-21 09:31</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Moderna (MRNA) is set to join the S&amp;P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock hassoaredamid the pandemic after its vaccine became instrumental in the fight against coronavirus.</p><p><blockquote>Moderna(MRNA)将于周三加入标普500指数，取代Alexion Pharmaceuticals Inc.(ALXN)。在其疫苗在对抗冠状病毒方面发挥作用后，该股在大流行期间飙升。</blockquote></p><p> Moderna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It's priced in a huge amount of assumptions over the next ten years that haven't played out yet. People believe it’s the Tesla of biotech.”</p><p><blockquote>杰富瑞(Jefferies)董事总经理兼高级研究分析师Michael Yee告诉雅虎财经（上面的视频），Moderna股票已经“拥有了自己的生命”。“它的定价包含了未来十年尚未实现的大量假设。人们相信这是生物技术的特斯拉。”</blockquote></p><p> That the biotech firm would be so well-recognized and valued at over $113 billion was no sure bet. For those who invested early in the company, that wager paid off.</p><p><blockquote>这家生物技术公司会得到如此广泛的认可并估值超过1130亿美元，这并不是一个确定的赌注。对于那些早期投资该公司的人来说，这一赌注得到了回报。</blockquote></p><p> \"Think about how fast they came up with nothing a year ago, and all of a sudden, they're doing $21 billion and have injected hundreds and hundreds and hundreds of millions of people with their drug safely,\" Yee said. \"That's a pretty big accomplishment.\"</p><p><blockquote>“想想看，一年前他们什么也没拿出，但突然之间，他们就赚了210亿美元，并为数以亿计的人安全地注射了药物，”Yee说。“这是一个相当大的成就。”</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bb60075c3a90de67d77af15634fd41fa\" tg-width=\"858\" tg-height=\"588\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <b>Moderna's rise to recognition</b></p><p><blockquote><b>Moderna获得认可</b></blockquote></p><p> The Cambridge, Massachusetts-based biotech company was founded in 2010 and spent its first two years instealth modedeveloping drugs using messenger RNA (mRNA).</p><p><blockquote>这家总部位于马萨诸塞州剑桥的生物技术公司成立于2010年，头两年一直在秘密开发使用信使RNA(mRNA)的药物。</blockquote></p><p> The promise of mRNA — what Moderna calls \"the software of life\" — in pharmaceuticals has been huge. Modified mRNA teaches cells how to produce the proteins needed to fight and prevent infection. By altering the four letters in an mRNA sequence, this new class of drugs can, in theory, target a wide range of illnesses. The mRNA platform also promises to accelerate the time it takes to select, develop, and manufacture vaccines.</p><p><blockquote>mRNA——现代评级的“生命软件”——在制药领域的前景是巨大的。修饰的mRNA教会细胞如何产生对抗和预防感染所需的蛋白质。通过改变mRNA序列中的四个字母，这种新型药物理论上可以针对多种疾病。mRNA平台还有望加快选择、开发和制造疫苗所需的时间。</blockquote></p><p> On these high expectations, Moderna achieved a billion-dollar valuation within two years. Initially, the company focused its efforts on treatments for cancer, cardiovascular issues, and some rare diseases. However, developers were embattled with the problem of delivering mRNA to cells — too-strong doses set the body's immune system against the drug while too-weak doses proved ineffectual in fighting disease.</p><p><blockquote>在这些高期望上，Moderna在两年内实现了10亿美元的估值。最初，该公司专注于癌症、心血管问题和一些罕见疾病的治疗。然而，开发人员面临着向细胞输送mRNA的问题——太强的剂量会使人体的免疫系统对药物产生抵抗力，而太弱的剂量则被证明对对抗疾病无效。</blockquote></p><p> Over time, the company shifted to pursuing vaccines, which CEO Stéphane Bancel believed would demonstrate the viability of the technology. Moderna had nine vaccines that made it to clinical trials, although none achieved liftoff.</p><p><blockquote>随着时间的推移，该公司转向开发疫苗，首席执行官Stéphane Bancel认为这将证明该技术的可行性。Moderna有九种疫苗进入临床试验，但没有一种疫苗成功上市。</blockquote></p><p> That changed when a deadly global pandemic hit, kicking off a vaccine race in the U.S. between Moderna and pharmaceutical titans like Pfizer (who also developed an mRNA vaccine in partnership with BioNTech) and Johnson &amp; Johnson.</p><p><blockquote>当致命的全球大流行来袭时，情况发生了变化，Moderna与辉瑞（辉瑞也与BioNTech合作开发了mRNA疫苗）和强生等制药巨头在美国开始了疫苗竞赛。</blockquote></p><p> The company's decade of research iterating on the basic science behind mRNA proved consequential in its success in developing a coronavirus vaccine in record time. On January 11, 2020, Chinese scientists revealed the genetic sequence for SARS-CoV-2. By February 24, 2020, Moderna shipped thefirst dosesof its mRNA coronavirus vaccine to the NIAID to begin phase I trials. And in December of 2020, phase III trials demonstrated 94.1% efficacy against symptomatic COVID-19. The FDA subsequently approved Moderna's vaccine for emergency use in the United States, Canada, and the European Union.</p><p><blockquote>事实证明，该公司对mRNA背后的基础科学进行了十年的迭代研究，对其在创纪录的时间内成功开发出冠状病毒疫苗至关重要。2020年1月11日，中国科学家揭示了新型冠状病毒病毒的基因序列。到2020年2月24日，Moderna将第一剂mRNA冠状病毒疫苗运送到NIAID，开始I期试验。2020年12月，III期试验显示对有症状的COVID-19有94.1%的疗效。FDA随后批准Moderna的疫苗在美国、加拿大和欧盟紧急使用。</blockquote></p><p> Moderna's COVID-19 vaccine marks its first — and only — commercially available product. On the back of strong demand for the vaccine, the company recorded its first-everprofitable quarterin Q1.</p><p><blockquote>Moderna的COVID-19疫苗标志着其第一个也是唯一一个商业化的产品。由于对疫苗的强劲需求，该公司在第一季度首次实现盈利。</blockquote></p><p> The company currently has 23 othervaccines and therapeuticsin its pipeline, including vaccines for the flu, HIV, and Cytomegalovirus (CMV), which causes birth defects in newborns, all using the same mRNA technology that has seen validation from the rollout of the COVID-19 vaccine.</p><p><blockquote>该公司目前还有23种其他疫苗和治疗药物，包括流感、艾滋病毒和导致新生儿出生缺陷的巨细胞病毒(CMV)疫苗，所有这些疫苗都使用相同的mRNA技术，该技术已在COVID-19的推出中得到验证-19疫苗。</blockquote></p><p> \"I think depending on your long-term outlook of what this company could do and all of the pipeline drugs that theoretically could come about over the next 10 years, based on those prospects, it could and should be one of the largest biotech companies in the world,\" Yee said.</p><p><blockquote>“我认为，根据你对这家公司可以做什么的长期前景以及理论上未来10年可能出现的所有管道药物，基于这些前景，它可以而且应该成为世界上最大的生物技术公司之一，”Yee说。</blockquote></p><p> <b>A bull market in biotech</b></p><p><blockquote><b>生物技术牛市</b></blockquote></p><p> The biotech industry has seen a phenomenal run-up in the last several years, and any pullbacks in the last six months should be viewed in that context, Yee also noted.</p><p><blockquote>Yee还指出，生物技术行业在过去几年中经历了惊人的增长，过去六个月的任何回调都应该在这种背景下看待。</blockquote></p><p> \"It has been one of the biggest bull markets in biotech in the last three years,\" he said, citing high valuations as well as record numbers of financings, investment, and IPOs.</p><p><blockquote>“这是过去三年生物技术领域最大的牛市之一，”他表示，并引用了高估值以及创纪录的融资、投资和IPO数量。</blockquote></p><p> Going forward, Yee expects more M&amp;A activity. \"Some of the large companies which are more mature, I think, are having some struggles. And the way they've solved that is often by buying smaller companies,\" he said. \"In the big picture, things have still been very good for biotech.\"</p><p><blockquote>展望未来，Yee预计并购活动将会增加。“我认为，一些更成熟的大公司正在遇到一些困难。他们解决这个问题的方法通常是收购较小的公司，”他说。“从大局来看，生物技术的情况仍然非常好。”</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/moderna-stock-sp-500-134049499.html\">finance.yahoo</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ALXN":"亚力兄制药","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-stock-sp-500-134049499.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120529749","content_text":"Moderna (MRNA) is set to join the S&P 500 index on Wednesday, replacing Alexion Pharmaceuticals Inc. (ALXN). The stock hassoaredamid the pandemic after its vaccine became instrumental in the fight against coronavirus.\nModerna stock has “taken on a life of its own,” Michael Yee, Managing Director and Senior Research Analyst at Jefferies, told Yahoo Finance (video above). “It's priced in a huge amount of assumptions over the next ten years that haven't played out yet. People believe it’s the Tesla of biotech.”\nThat the biotech firm would be so well-recognized and valued at over $113 billion was no sure bet. For those who invested early in the company, that wager paid off.\n\"Think about how fast they came up with nothing a year ago, and all of a sudden, they're doing $21 billion and have injected hundreds and hundreds and hundreds of millions of people with their drug safely,\" Yee said. \"That's a pretty big accomplishment.\"\n\nModerna's rise to recognition\nThe Cambridge, Massachusetts-based biotech company was founded in 2010 and spent its first two years instealth modedeveloping drugs using messenger RNA (mRNA).\nThe promise of mRNA — what Moderna calls \"the software of life\" — in pharmaceuticals has been huge. Modified mRNA teaches cells how to produce the proteins needed to fight and prevent infection. By altering the four letters in an mRNA sequence, this new class of drugs can, in theory, target a wide range of illnesses. The mRNA platform also promises to accelerate the time it takes to select, develop, and manufacture vaccines.\nOn these high expectations, Moderna achieved a billion-dollar valuation within two years. Initially, the company focused its efforts on treatments for cancer, cardiovascular issues, and some rare diseases. However, developers were embattled with the problem of delivering mRNA to cells — too-strong doses set the body's immune system against the drug while too-weak doses proved ineffectual in fighting disease.\nOver time, the company shifted to pursuing vaccines, which CEO Stéphane Bancel believed would demonstrate the viability of the technology. Moderna had nine vaccines that made it to clinical trials, although none achieved liftoff.\nThat changed when a deadly global pandemic hit, kicking off a vaccine race in the U.S. between Moderna and pharmaceutical titans like Pfizer (who also developed an mRNA vaccine in partnership with BioNTech) and Johnson & Johnson.\nThe company's decade of research iterating on the basic science behind mRNA proved consequential in its success in developing a coronavirus vaccine in record time. On January 11, 2020, Chinese scientists revealed the genetic sequence for SARS-CoV-2. By February 24, 2020, Moderna shipped thefirst dosesof its mRNA coronavirus vaccine to the NIAID to begin phase I trials. And in December of 2020, phase III trials demonstrated 94.1% efficacy against symptomatic COVID-19. The FDA subsequently approved Moderna's vaccine for emergency use in the United States, Canada, and the European Union.\nModerna's COVID-19 vaccine marks its first — and only — commercially available product. On the back of strong demand for the vaccine, the company recorded its first-everprofitable quarterin Q1.\nThe company currently has 23 othervaccines and therapeuticsin its pipeline, including vaccines for the flu, HIV, and Cytomegalovirus (CMV), which causes birth defects in newborns, all using the same mRNA technology that has seen validation from the rollout of the COVID-19 vaccine.\n\"I think depending on your long-term outlook of what this company could do and all of the pipeline drugs that theoretically could come about over the next 10 years, based on those prospects, it could and should be one of the largest biotech companies in the world,\" Yee said.\nA bull market in biotech\nThe biotech industry has seen a phenomenal run-up in the last several years, and any pullbacks in the last six months should be viewed in that context, Yee also noted.\n\"It has been one of the biggest bull markets in biotech in the last three years,\" he said, citing high valuations as well as record numbers of financings, investment, and IPOs.\nGoing forward, Yee expects more M&A activity. \"Some of the large companies which are more mature, I think, are having some struggles. And the way they've solved that is often by buying smaller companies,\" he said. \"In the big picture, things have still been very good for biotech.\"","news_type":1,"symbols_score_info":{"MRNA":0.9,"ALXN":0.9}},"isVote":1,"tweetType":1,"viewCount":746,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178417706,"gmtCreate":1626831743605,"gmtModify":1631886459250,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Solid","listText":"Solid","text":"Solid","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/178417706","repostId":"2153924256","repostType":4,"isVote":1,"tweetType":1,"viewCount":955,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":153188721,"gmtCreate":1625013615463,"gmtModify":1631886459264,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/153188721","repostId":"1122418477","repostType":4,"isVote":1,"tweetType":1,"viewCount":1893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":121720522,"gmtCreate":1624493066566,"gmtModify":1631886459276,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/121720522","repostId":"2145156570","repostType":4,"isVote":1,"tweetType":1,"viewCount":1650,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165222082,"gmtCreate":1624148010546,"gmtModify":1631886459290,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/165222082","repostId":"1113942445","repostType":4,"isVote":1,"tweetType":1,"viewCount":1042,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162297351,"gmtCreate":1624064010573,"gmtModify":1631886459299,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Shucks","listText":"Shucks","text":"Shucks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/162297351","repostId":"1156696708","repostType":4,"isVote":1,"tweetType":1,"viewCount":1882,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132351363,"gmtCreate":1622073447352,"gmtModify":1631886459313,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Nicely done","listText":"Nicely done","text":"Nicely done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/132351363","repostId":"2138141854","repostType":4,"isVote":1,"tweetType":1,"viewCount":2240,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":199269233,"gmtCreate":1620708424722,"gmtModify":1631886459332,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/199269233","repostId":"2134551566","repostType":4,"isVote":1,"tweetType":1,"viewCount":1103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109623077,"gmtCreate":1619693016499,"gmtModify":1631886459345,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Flyyyyy","listText":"Flyyyyy","text":"Flyyyyy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/109623077","repostId":"1140991024","repostType":4,"isVote":1,"tweetType":1,"viewCount":1108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":100087526,"gmtCreate":1619569754165,"gmtModify":1631886459358,"author":{"id":"3567633296951464","authorId":"3567633296951464","name":"SGHuatZai","avatar":"https://static.tigerbbs.com/7dd5a1a160261cba3acf6da0e9110862","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567633296951464","authorIdStr":"3567633296951464"},"themes":[],"htmlText":"Amazing 👍🏻","listText":"Amazing 👍🏻","text":"Amazing 👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/100087526","repostId":"1187199105","repostType":4,"repost":{"id":"1187199105","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619566832,"share":"https://www.laohu8.com/m/news/1187199105?lang=zh_CN&edition=full","pubTime":"2021-04-28 07:40","market":"us","language":"en","title":"AMD stock rises after earnings show data-center sales more than doubling<blockquote>财报显示数据中心销售额增长一倍多后，AMD股价上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1187199105","media":"Tiger Newspress","summary":"AMD increases full-year revenue guidance after record quarterly sales, stock jumps more than 3% in e","content":"<p>AMD increases full-year revenue guidance after record quarterly sales, stock jumps more than 3% in extended session<img src=\"https://static.tigerbbs.com/174cfb55080b96346856b267d6c023ed\" tg-width=\"706\" tg-height=\"523\" referrerpolicy=\"no-referrer\">Advanced Micro Devices Inc. shares rose in the extended session Tuesday after the chip maker said data-center revenue more than doubled to fuel record quarterly sales, and increased its revenue forecast for the year.</p><p><blockquote>AMD在创纪录的季度销售额后上调全年收入指引，股价在延长交易时段上涨逾3%芯片制造商Advanced Micro Devices Inc.表示，数据中心收入增长了一倍多，推动了创纪录的季度销售额，并上调了今年的收入预期，该公司股价在周二的延长交易中上涨。</blockquote></p><p>“In the first quarter, data-center product revenue more than doubled year-over-year and represented a high teens percentage of our overall revenue,” said AMD&nbsp;Chief Executive Lisa Su on a call with analysts. “We expect data-center product revenue to grow significantly as we go through the year driven by our strong pipeline of new cloud, enterprise and [high-performance computing] wins.”</p><p><blockquote>AMD首席执行官苏姿丰在与分析师的看涨期权中表示：“第一季度，数据中心产品收入同比增长了一倍多，占我们总收入的比例很高。”“我们预计，在我们强大的新云、企业和[高性能计算]胜利渠道的推动下，数据中心产品收入将在今年大幅增长。”</blockquote></p><p>Sales from enterprise embedded and semi-custom chips — the unit that includes data-center and gaming-console revenue — nearly quadrupled to $1.35 billion, compared with $348 million a year ago. Analysts surveyed by FactSet expected $1.3 billion. Su’s comments about data-center revenue were helpful asAMD does not break out data-center sales from gaming sales.</p><p><blockquote>企业嵌入式和半定制芯片（包括数据中心和游戏机收入）的销售额几乎翻了两番，达到13.5亿美元，而一年前为3.48亿美元。FactSet调查的分析师预计为13亿美元。苏关于数据中心收入的评论很有帮助，因为AMD不会将数据中心销售额与游戏销售额分开。</blockquote></p><p>“I think we saw actually strong signals in the first quarter that it would be a strong data-center year for us,” Su told analysts.</p><p><blockquote>“我认为我们在第一季度看到了真正强烈的信号，表明今年对我们来说将是数据中心强劲的一年，”苏告诉分析师。</blockquote></p><p>Last week, Intel Corp&nbsp;said the data-center market was in a“digestion phase,”contributing to a 20% drop in sales for data centers, yetanalysts pointed to increased competition from AMD and ARM Holdings PLC.</p><p><blockquote>上周，英特尔公司表示，数据中心市场正处于“消化阶段”，导致数据中心销售额下降20%，但分析师指出，来自AMD和ARM Holdings PLC的竞争加剧。</blockquote></p><p>AMD reported first-quarter net income of $555 million, or 45 cents a share, compared with $162 million, or 14 cents a share, in the year-ago period. After adjusting for stock-based compensation and other factors, the Santa Clara, Calif.-based company reported earnings of 52 cents a share, compared with 18 cents a share in the year-ago period. Revenue rose to $3.45 billion from $1.79 billion in the year-ago quarter.</p><p><blockquote>AMD公布第一季度净利润为5.55亿美元，即每股45美分，而去年同期为1.62亿美元，即每股14美分。在调整股票薪酬和其他因素后，这家总部位于加利福尼亚州圣克拉拉的公司报告每股收益为52美分，而去年同期为每股18美分。收入从去年同期的17.9亿美元增至34.5亿美元。</blockquote></p><p>Analysts surveyed by FactSet had forecast adjusted earnings of 44 cents a share on revenue of $3.18 billion, and AMD projected between $3.1 billion and $3.3 billion.</p><p><blockquote>FactSet调查的分析师此前预测调整后每股收益为44美分，营收为31.8亿美元，AMD预计在31亿至33亿美元之间。</blockquote></p><p>AMD reported first-quarter sales of $2.1 billion for computing and graphics chips, up 46% from $1.44 billion last year, compared with analyst expectations of $1.89 billion.</p><p><blockquote>AMD公布第一季度计算和图形芯片销售额为21亿美元，较去年的14.4亿美元增长46%，分析师预期为18.9亿美元。</blockquote></p><p>Executives also increased AMD’s guidance for the full year, to a sales increase of about 50% from previous guidance of a roughly 37% increase. AMD reported revenue of $9.67 billion last year, suggesting sales of about $14.65 billion this year; analysts had been forecasting revenue of $13.46 billion, according to FactSet.</p><p><blockquote>高管们还提高了AMD全年销售额指引，从之前指引的约37%增长至约50%。AMD去年营收为96.7亿美元，暗示今年销售额约为146.5亿美元；FactSet的数据显示，分析师此前预测营收为134.6亿美元。</blockquote></p><p>AMD expects second-quarter revenue of $3.5 billion to $3.7 billion, while analysts had been projecting $3.23 billion, according to FactSet.</p><p><blockquote>FactSet的数据显示，AMD预计第二季度营收为35亿至37亿美元，而分析师此前预计为32.3亿美元。</blockquote></p><p>Shares gained more than 3% in after-hours trading, following a 0.2% decline in the regular session to close at $85.21.</p><p><blockquote>该股在常规交易中下跌0.2%，收于85.21美元，在盘后交易中上涨超过3%。</blockquote></p><p>AMD’s strong earnings come amid a continuing shortage of microchips to sate demand from global industries, and the companies that make the silicon wafers that chip designs use, work to clear waiting lists that span several months.</p><p><blockquote>AMD的强劲盈利是在满足全球行业需求的微芯片持续短缺的情况下出现的，而制造芯片设计所用硅片的公司正在努力清理长达数月的等待名单。</blockquote></p><p>More of how the chip sector is dealing with supply shortages will be revealed this week, with Qualcomm Inc.QCOM,-0.68%earnings on Wednesday and KLA Corp.KLAC,-1.58%earnings on Thursday.</p><p><blockquote>芯片行业如何应对供应短缺的更多信息将于本周公布，高通公司(Qualcomm Inc.QCOM)周三盈利-0.68%，KLA Corp.KLAC(KLAC)周四盈利-1.58%。</blockquote></p><p>Over the past 12 months, AMD shares have gained 51%. In comparison, the PHLX Semiconductor IndexSOX,-0.76%has gained 87%, the S&amp;P 500 index&nbsp;has risen 54%, and the tech-heavy Nasdaq Composite Index&nbsp;is up 61%.</p><p><blockquote>过去12个月，AMD股价上涨了51%。相比之下，PHLX半导体指数SOX,-0.76%上涨87%，标普500指数上涨54%，以科技股为主的纳斯达克综合指数上涨61%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMD stock rises after earnings show data-center sales more than doubling<blockquote>财报显示数据中心销售额增长一倍多后，AMD股价上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMD stock rises after earnings show data-center sales more than doubling<blockquote>财报显示数据中心销售额增长一倍多后，AMD股价上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-04-28 07:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>AMD increases full-year revenue guidance after record quarterly sales, stock jumps more than 3% in extended session<img src=\"https://static.tigerbbs.com/174cfb55080b96346856b267d6c023ed\" tg-width=\"706\" tg-height=\"523\" referrerpolicy=\"no-referrer\">Advanced Micro Devices Inc. shares rose in the extended session Tuesday after the chip maker said data-center revenue more than doubled to fuel record quarterly sales, and increased its revenue forecast for the year.</p><p><blockquote>AMD在创纪录的季度销售额后上调全年收入指引，股价在延长交易时段上涨逾3%芯片制造商Advanced Micro Devices Inc.表示，数据中心收入增长了一倍多，推动了创纪录的季度销售额，并上调了今年的收入预期，该公司股价在周二的延长交易中上涨。</blockquote></p><p>“In the first quarter, data-center product revenue more than doubled year-over-year and represented a high teens percentage of our overall revenue,” said AMD&nbsp;Chief Executive Lisa Su on a call with analysts. “We expect data-center product revenue to grow significantly as we go through the year driven by our strong pipeline of new cloud, enterprise and [high-performance computing] wins.”</p><p><blockquote>AMD首席执行官苏姿丰在与分析师的看涨期权中表示：“第一季度，数据中心产品收入同比增长了一倍多，占我们总收入的比例很高。”“我们预计，在我们强大的新云、企业和[高性能计算]胜利渠道的推动下，数据中心产品收入将在今年大幅增长。”</blockquote></p><p>Sales from enterprise embedded and semi-custom chips — the unit that includes data-center and gaming-console revenue — nearly quadrupled to $1.35 billion, compared with $348 million a year ago. Analysts surveyed by FactSet expected $1.3 billion. Su’s comments about data-center revenue were helpful asAMD does not break out data-center sales from gaming sales.</p><p><blockquote>企业嵌入式和半定制芯片（包括数据中心和游戏机收入）的销售额几乎翻了两番，达到13.5亿美元，而一年前为3.48亿美元。FactSet调查的分析师预计为13亿美元。苏关于数据中心收入的评论很有帮助，因为AMD不会将数据中心销售额与游戏销售额分开。</blockquote></p><p>“I think we saw actually strong signals in the first quarter that it would be a strong data-center year for us,” Su told analysts.</p><p><blockquote>“我认为我们在第一季度看到了真正强烈的信号，表明今年对我们来说将是数据中心强劲的一年，”苏告诉分析师。</blockquote></p><p>Last week, Intel Corp&nbsp;said the data-center market was in a“digestion phase,”contributing to a 20% drop in sales for data centers, yetanalysts pointed to increased competition from AMD and ARM Holdings PLC.</p><p><blockquote>上周，英特尔公司表示，数据中心市场正处于“消化阶段”，导致数据中心销售额下降20%，但分析师指出，来自AMD和ARM Holdings PLC的竞争加剧。</blockquote></p><p>AMD reported first-quarter net income of $555 million, or 45 cents a share, compared with $162 million, or 14 cents a share, in the year-ago period. After adjusting for stock-based compensation and other factors, the Santa Clara, Calif.-based company reported earnings of 52 cents a share, compared with 18 cents a share in the year-ago period. Revenue rose to $3.45 billion from $1.79 billion in the year-ago quarter.</p><p><blockquote>AMD公布第一季度净利润为5.55亿美元，即每股45美分，而去年同期为1.62亿美元，即每股14美分。在调整股票薪酬和其他因素后，这家总部位于加利福尼亚州圣克拉拉的公司报告每股收益为52美分，而去年同期为每股18美分。收入从去年同期的17.9亿美元增至34.5亿美元。</blockquote></p><p>Analysts surveyed by FactSet had forecast adjusted earnings of 44 cents a share on revenue of $3.18 billion, and AMD projected between $3.1 billion and $3.3 billion.</p><p><blockquote>FactSet调查的分析师此前预测调整后每股收益为44美分，营收为31.8亿美元，AMD预计在31亿至33亿美元之间。</blockquote></p><p>AMD reported first-quarter sales of $2.1 billion for computing and graphics chips, up 46% from $1.44 billion last year, compared with analyst expectations of $1.89 billion.</p><p><blockquote>AMD公布第一季度计算和图形芯片销售额为21亿美元，较去年的14.4亿美元增长46%，分析师预期为18.9亿美元。</blockquote></p><p>Executives also increased AMD’s guidance for the full year, to a sales increase of about 50% from previous guidance of a roughly 37% increase. AMD reported revenue of $9.67 billion last year, suggesting sales of about $14.65 billion this year; analysts had been forecasting revenue of $13.46 billion, according to FactSet.</p><p><blockquote>高管们还提高了AMD全年销售额指引，从之前指引的约37%增长至约50%。AMD去年营收为96.7亿美元，暗示今年销售额约为146.5亿美元；FactSet的数据显示，分析师此前预测营收为134.6亿美元。</blockquote></p><p>AMD expects second-quarter revenue of $3.5 billion to $3.7 billion, while analysts had been projecting $3.23 billion, according to FactSet.</p><p><blockquote>FactSet的数据显示，AMD预计第二季度营收为35亿至37亿美元，而分析师此前预计为32.3亿美元。</blockquote></p><p>Shares gained more than 3% in after-hours trading, following a 0.2% decline in the regular session to close at $85.21.</p><p><blockquote>该股在常规交易中下跌0.2%，收于85.21美元，在盘后交易中上涨超过3%。</blockquote></p><p>AMD’s strong earnings come amid a continuing shortage of microchips to sate demand from global industries, and the companies that make the silicon wafers that chip designs use, work to clear waiting lists that span several months.</p><p><blockquote>AMD的强劲盈利是在满足全球行业需求的微芯片持续短缺的情况下出现的，而制造芯片设计所用硅片的公司正在努力清理长达数月的等待名单。</blockquote></p><p>More of how the chip sector is dealing with supply shortages will be revealed this week, with Qualcomm Inc.QCOM,-0.68%earnings on Wednesday and KLA Corp.KLAC,-1.58%earnings on Thursday.</p><p><blockquote>芯片行业如何应对供应短缺的更多信息将于本周公布，高通公司(Qualcomm Inc.QCOM)周三盈利-0.68%，KLA Corp.KLAC(KLAC)周四盈利-1.58%。</blockquote></p><p>Over the past 12 months, AMD shares have gained 51%. In comparison, the PHLX Semiconductor IndexSOX,-0.76%has gained 87%, the S&amp;P 500 index&nbsp;has risen 54%, and the tech-heavy Nasdaq Composite Index&nbsp;is up 61%.</p><p><blockquote>过去12个月，AMD股价上涨了51%。相比之下，PHLX半导体指数SOX,-0.76%上涨87%，标普500指数上涨54%，以科技股为主的纳斯达克综合指数上涨61%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187199105","content_text":"AMD increases full-year revenue guidance after record quarterly sales, stock jumps more than 3% in extended sessionAdvanced Micro Devices Inc. shares rose in the extended session Tuesday after the chip maker said data-center revenue more than doubled to fuel record quarterly sales, and increased its revenue forecast for the year.“In the first quarter, data-center product revenue more than doubled year-over-year and represented a high teens percentage of our overall revenue,” said AMD Chief Executive Lisa Su on a call with analysts. “We expect data-center product revenue to grow significantly as we go through the year driven by our strong pipeline of new cloud, enterprise and [high-performance computing] wins.”Sales from enterprise embedded and semi-custom chips — the unit that includes data-center and gaming-console revenue — nearly quadrupled to $1.35 billion, compared with $348 million a year ago. Analysts surveyed by FactSet expected $1.3 billion. Su’s comments about data-center revenue were helpful asAMD does not break out data-center sales from gaming sales.“I think we saw actually strong signals in the first quarter that it would be a strong data-center year for us,” Su told analysts.Last week, Intel Corp said the data-center market was in a“digestion phase,”contributing to a 20% drop in sales for data centers, yetanalysts pointed to increased competition from AMD and ARM Holdings PLC.AMD reported first-quarter net income of $555 million, or 45 cents a share, compared with $162 million, or 14 cents a share, in the year-ago period. After adjusting for stock-based compensation and other factors, the Santa Clara, Calif.-based company reported earnings of 52 cents a share, compared with 18 cents a share in the year-ago period. Revenue rose to $3.45 billion from $1.79 billion in the year-ago quarter.Analysts surveyed by FactSet had forecast adjusted earnings of 44 cents a share on revenue of $3.18 billion, and AMD projected between $3.1 billion and $3.3 billion.AMD reported first-quarter sales of $2.1 billion for computing and graphics chips, up 46% from $1.44 billion last year, compared with analyst expectations of $1.89 billion.Executives also increased AMD’s guidance for the full year, to a sales increase of about 50% from previous guidance of a roughly 37% increase. AMD reported revenue of $9.67 billion last year, suggesting sales of about $14.65 billion this year; analysts had been forecasting revenue of $13.46 billion, according to FactSet.AMD expects second-quarter revenue of $3.5 billion to $3.7 billion, while analysts had been projecting $3.23 billion, according to FactSet.Shares gained more than 3% in after-hours trading, following a 0.2% decline in the regular session to close at $85.21.AMD’s strong earnings come amid a continuing shortage of microchips to sate demand from global industries, and the companies that make the silicon wafers that chip designs use, work to clear waiting lists that span several months.More of how the chip sector is dealing with supply shortages will be revealed this week, with Qualcomm Inc.QCOM,-0.68%earnings on Wednesday and KLA Corp.KLAC,-1.58%earnings on Thursday.Over the past 12 months, AMD shares have gained 51%. In comparison, the PHLX Semiconductor IndexSOX,-0.76%has gained 87%, the S&P 500 index has risen 54%, and the tech-heavy Nasdaq Composite Index is up 61%.","news_type":1,"symbols_score_info":{"AMD":0.9}},"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}